Adherence to surveillance among patients with superficial bladder cancer Journal Article


Authors: Schrag, D.; Hsieh, L.; Rabbani, F.; Bach, P. B.; Herr, H.; Begg, C. B.
Article Title: Adherence to surveillance among patients with superficial bladder cancer
Abstract: Background: Patients diagnosed with superficial bladder cancer who have not undergone total cystectomy are at high risk for recurrence, and bladder surveillance with cystoscopy is recommended for such patients every 3-6 months. We examined the degree to which bladder cancer patients undergo the recommended surveillance procedures and identified patient and primary care provider characteristics associated with nonadherence to these recommendations. Methods: We used information obtained from the Surveillance, Epidemiology, and End Results (SEER) Program-Medicare-linked database to identify 6717 patients aged 65 years or older who were diagnosed with superficial bladder cancer from 1992 through 1996 and who survived for at least 3 years after diagnosis but did not have a total cystectomy. We used information obtained from Medicare claims forms to examine the frequency with which these patients had a surveillance examination of the bladder during each of five contiguous 6-month intervals from month 7 to month 36 following diagnosis. We examined characteristics of patients and their physicians that were associated with low-intensity surveillance (defined as having an examination during fewer than two of the five possible follow-up intervals). Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). All statistical tests were two-sided. Results: Only 40% of the entire cohort had an examination during all five intervals; 1216 patients (18.1%) had low-intensity surveillance. Patient characteristics that were independently associated with low-intensity surveillance were being age 75 years or older (adjusted OR = 1.54, 95% CI = 1.35 to 1.74), nonwhite (adjusted OR = 1.94, 95% CI = 1.57 to 2.40), and having favorable tumor histology (adjusted OR = 0.59, 95% CI = 0.48 to 0.72 for poorly differentiated versus referent well-differentiated tumor grade) and high comorbidity (adjusted OR = 1.72, 95% CI = 1.30 to 2.27). Residence in an urban area or in a census tract with low median income was also associated with low-intensity surveillance. Conclusions: The actual practice of surveillance for patients with superficial bladder cancer differs substantially from the standards recommended in clinical guidelines.
Keywords: cancer survival; controlled study; aged; aged, 80 and over; major clinical study; histopathology; cancer recurrence; united states; cancer patient; recurrence risk; follow up; cancer grading; clinical practice; demography; tumor differentiation; cohort analysis; odds ratio; recurrence; practice guideline; data base; bladder cancer; urinary bladder neoplasms; age; risk assessment; risk; health care quality; health program; medicare; patient information; statistical analysis; physicians; cystectomy; comorbidity; patient compliance; seer program; cystoscopy; physician attitude; guideline adherence; logistic regression analysis; population surveillance; patient attitude; primary medical care; negro; periodic medical examination; lowest income group; practice guidelines; urban area; humans; human; male; female; priority journal; article
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 95
Issue: 8
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2003-04-16
Start Page: 588
End Page: 597
Language: English
PUBMED: 12697851
PROVIDER: scopus
DOI: 10.1093/jnci/95.8.588
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lillian Hsieh
    4 Hsieh
  2. Colin B Begg
    306 Begg
  3. Farhang Rabbani
    84 Rabbani
  4. Deborah Schrag
    229 Schrag
  5. Peter Bach
    255 Bach
  6. Harry W Herr
    594 Herr